Research ArticleOriginal Article
Open Access

Impact of diabetes mellitus and co-morbidities on mortality in patients with COVID-19

A single-center retrospective study

Anees A. Sindi, Wail A. Tashkandi, Mohammed W. Jastaniah, Mohammed A. Bashanfar, Ahmed F. Fakhri, Fahad S. Alsallum, Hamdan B. Alguydi, Alyaa Elhazmi, Talal A. Al-Khatib, Maha M. Alawi and Ibrahim Abushoshah
Saudi Medical Journal January 2023, 44 (1) 67-73; DOI: https://doi.org/10.15537/smj.2023.44.1.20220462

References

  1. 1.↵
    1. Meo SA,
    2. Alhowikan AM,
    3. Al-Khlaiwi T,
    4. Meo IM,
    5. Halepoto DM,
    6. Iqbal M, et al.
    Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci 2020; 24: 2012-2019.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Schoen K,
    2. Horvat N,
    3. Guerreiro NFC,
    4. de Castro I,
    5. de Giassi KS.
    Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis 2019; 19: 964.
    OpenUrlPubMed
  3. 3.
    1. Yang JK,
    2. Feng Y,
    3. Yuan MY,
    4. Yuan SY,
    5. Fu HJ,
    6. Wu BY, et al.
    Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 2006; 23: 623-628.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Banik GR,
    2. Alqahtani AS,
    3. Booy R,
    4. Rashid H.
    Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia. Virol Sin 2016; 31: 81-84.
    OpenUrlCrossRef
  5. 5.↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y, et al.
    Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
    OpenUrlCrossRefPubMed
  6. 6.
    1. Zhang JJ,
    2. Dong X,
    3. Cao YY,
    4. Yuan YD,
    5. Yang YB,
    6. Yan YQ, et al.
    Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75: 1730-1741.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Wu C,
    2. Chen X,
    3. Cai Y,
    4. Xia J,
    5. Zhou X,
    6. Xu S, et al.
    Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; 180: 934-943.
    OpenUrl
  8. 8.↵
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. Zhu F,
    5. Liu X,
    6. Zhang J, et al.
    Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061-1069.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Jafar N,
    2. Edriss H,
    3. Nugent K.
    The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci 2016; 351: 201-211.
    OpenUrlPubMed
  10. 10.↵
    1. Guo W,
    2. Li M,
    3. Dong Y,
    4. Zhou H,
    5. Zhang Z,
    6. Tian C, et al.
    Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020; 36: e3319.
    OpenUrl
  11. 11.↵
    1. Cariou B,
    2. Hadjadj S,
    3. Wargny M,
    4. Pichelin M,
    5. Al-Salameh A,
    6. Allix I, et al.
    Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia 2020; 63: 1500-1515.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Zhu L,
    2. She ZG,
    3. Cheng X,
    4. Qin JJ,
    5. Zhang XJ,
    6. Cai J, et al.
    Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 2020; 31: 1068-1077.
    OpenUrlCrossRefPubMed
  13. 13.↵
    Centers for Disease Control and Prevention. Morbidity and mortality weekly report: novel coronavirus reports. [Updated 2020; accessed 2020 May 14]. Available from: https://www.cdc.gov/mmwr/Novel_Coronavirus_Reports.html
  14. 14.↵
    1. Alshukry A,
    2. Ali H,
    3. Ali Y,
    4. Al-Taweel T,
    5. Abu-Farha M,
    6. AbuBaker J, et al.
    Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait. PLoS One 2020; 15: e0242768.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Mo P,
    2. Xing Y,
    3. Xiao Y,
    4. Deng L,
    5. Zhao Q,
    6. Wang H, et al.
    Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2021; 73: e4208-e4213.
    OpenUrl
  16. 16.↵
    1. Wu J,
    2. Liu J,
    3. Zhao X,
    4. Liu C,
    5. Wang W,
    6. Wang D, et al.
    Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis 2020; 71: 706-712.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Wan S,
    2. Xiang Y,
    3. Fang W,
    4. Zheng Y,
    5. Li B,
    6. Hu Y, et al.
    Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol 2020; 92: 797-806.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Soeroto AY,
    2. Soetedjo NN,
    3. Purwiga A,
    4. Santoso P,
    5. Kulsum ID,
    6. Suryadinata H, et al.
    Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: a systematic review and meta-analysis. Diabetes Metab Syndr 2020; 14: 1897-1904.
    OpenUrlCrossRef
  19. 19.↵
    1. Sattar N,
    2. McInnes IB,
    3. McMurray JJV.
    Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 2020; 142: 4-6.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Wang Z,
    2. Du Z,
    3. Zhu F.
    Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract 2020; 164: 108214.
    OpenUrlPubMed
  21. 21.↵
    1. Williamson EJ,
    2. Walker AJ,
    3. Bhaskaran K,
    4. Bacon S,
    5. Bates C,
    6. Morton CE, et al.
    Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584: 430-436.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Holman N,
    2. Knighton P,
    3. Kar P,
    4. O’Keefe J,
    5. Curley M,
    6. Weaver A, et al.
    Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 2020; 8: 823-833.
    OpenUrlPubMed
  23. 23.↵
    1. Muniyappa R,
    2. Gubbi S.
    COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab 2020; 318: E736-E741.
    OpenUrlPubMed
  24. 24.↵
    1. Yang JK,
    2. Lin SS,
    3. Ji XJ,
    4. Guo LM.
    Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010; 47: 193-199.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Hafidh K,
    2. Abbas S,
    3. Khan A,
    4. Kazmi T,
    5. Nazir Z,
    6. Aldaham T.
    The clinical characteristics and outcomes of COVID-19 infections in patients with diabetes at a tertiary care center in the UAE. Dubai Diabetes Endocrinol J 2020; 26: 158-163.
    OpenUrl
  26. 26.↵
    1. Jiang Y,
    2. Zhou X,
    3. Cheng L,
    4. Li M.
    The impact of smoking on subgingival microflora: from periodontal health to disease. Front Microbiol 2020; 11: 66.
    OpenUrl
  27. 27.↵
    1. Karanasos A,
    2. Aznaouridis K,
    3. Latsios G,
    4. Synetos A,
    5. Plitaria S,
    6. Tousoulis D, et al.
    Impact of smoking status on disease severity and mortality of hospitalized patients with COVID-19 infection: a systematic review and meta-analysis. Nicotine Tob Res 2020; 22: 1657-1659.
    OpenUrlPubMed
  28. 28.↵
    1. Lalueza A,
    2. Ayuso B,
    3. Arrieta E,
    4. Trujillo H,
    5. Folgueira D,
    6. Cueto C, et al.
    Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin Microbiol Infect 2020; 26: 1557.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Paliogiannis P,
    2. Zinellu A,
    3. Scano V,
    4. Mulas G,
    5. De Riu G,
    6. Pascale RM, et al.
    Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. J Infect Dev Ctries 2020; 14: 685-690.
    OpenUrlPubMed
  30. 30.↵
    1. Sproston NR,
    2. Ashworth JJ.
    Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018; 9: 754.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Li G,
    2. Deng Q,
    3. Feng J,
    4. Li F,
    5. Xiong N,
    6. He Q.
    Clinical characteristics of diabetic patients with COVID-19. J Diabetes Res 2020; 2020: 1652403.
    OpenUrl
  32. 32.↵
    1. Zaim S,
    2. Chong JH,
    3. Sankaranarayanan V,
    4. Harky A.
    COVID-19 and multiorgan response. Curr Probl Cardiol 2020; 45: 100618.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Corona G,
    2. Pizzocaro A,
    3. Vena W,
    4. Rastrelli G,
    5. Semeraro F,
    6. Isidori AM, et al.
    Diabetes is most important cause for mortality in COVID-19 hospitalized patients: systematic review and meta-analysis. Rev Endocr Metab Disord 2021; 22: 275-296.
    OpenUrlCrossRef
  34. 34.↵
    1. Kumar A,
    2. Arora A,
    3. Sharma P,
    4. Anikhindi SA,
    5. Bansal N,
    6. Singla V, et al.
    Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr 2020; 14: 535-545.
    OpenUrlPubMed
  35. 35.↵
    1. Abbas HM,
    2. Nassir KF,
    3. Al Khames Aga QA,
    4. Al-Gharawi AA,
    5. Rasheed JI,
    6. Al-Obaidy MW, et al.
    Presenting the characteristics, smoking versus diabetes, and outcome among patients hospitalized with COVID-19. J Med Virol 2021; 93: 1556-1567.
    OpenUrl
  36. 36.↵
    1. Dimova R,
    2. Stoyanova R,
    3. Blagoeva V,
    4. Mavrov M,
    5. Doykov M.
    COVID-19 mortality and related comorbidities in hospitalized patients in Bulgaria. Healthcare (Basel) 2022; 10: 1535.
    OpenUrl
  37. 37.↵
    1. Yoshida Y,
    2. Wang J,
    3. Zu Y.
    Gender differences in comorbidities and COVID-19 mortality-report from the real-world data. Front Public Health 2022; 10: 881660.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords